Public .eporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing Instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other aspect of this collection of Information, Including suggestions for reducing this burden to Washington Headquarters Services, Directorate for Information Operations and Reports, 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302, and to the Office of Management and Budget, Paperwork Reduction Project (0704-0188), Washington, DC 20503.
AGENCY USE ONLY (Leave blank)
2, REPORT DATE
REPORT TYPE AND DATES COVERED
I January 1999Annual 4. TITLE AND SUBTITLE
FUNDING NUMBERSAn Eye Oximeter for Combat Casualty Care DAMD179818007
AUTHOR(S)Denninghoff, Kurt, M.D.
PERFORMING ORGANIZATION NAMES(S) AND ADDRESS(ES)8
ABSTRACT (Maximum 200 words)Blood pressure and pulse are particularly inaccurate when used to identify early blood loss in trauma victims. This research supports the continued development of a system for noninvasively monitoring blood loss. We have developed a breadboard Eye Oximeter (EOX) which shines low power lasers into a subject's eye and scans the beams across the arteries and veins of the retina. The back reflected light is collected and from these signals, we calculate the oxygen saturation of the blood within the retinal vessels. Prior to initiating this contract, we completed swine studies that demonstrated a strong correlation between retinal venous oxygen saturation and early blood loss. During the past year, we have completed construction of a prototype Eye Oximeter, performed model eye experiments with this prototype which verify in vitro calibration, performed pilot human experiments which demonstrate significant improvements in our prototype, and begun animal testing of the device. We have also completed the development and design of a video oximeter (EOX-2) as anticipated in our statement of work. We have completed the construction of the EOX-2 breadboard and testing of the device has begun. In this Annual Report we document the studies, results and analysis which we performed under contract. (NIH Publication No. 86-23, Revised 1985).For the protection of human subjects, the investigator (s) have adhered to policies of applicable Federal Law 45 CFR 46.In conducting research utilizing recombinant DNA, the investigator(s) adhered to NIH Guidelines for Research Involving Recombinant DNA Molecules.In the conduct of research involving hazardous organisms, the investigator(s) adhered to the CDC-NIH Guide for Biosafety in Microbiological and Biomedical Laboratories.
IntroductionExsanguination is the most immediate life threatening danger for the field casualty during wartime. Indeed, 60% of all deaths from battlefield abdominal injuries are due to hemorrhage. If these casualties of war survive, they often require massive transfusions and sophis...